Cargando…
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Gemcitabine is an intravenously administered nucleoside analog chemotherapeutic agent. The ability to deliver this agent as an oral drug would allow greater flexibility of administration and patient convenience; however, attempts have been fraught with high first-pass metabolism and potential intest...
Autores principales: | Wickremsinhe, Enaksha, Bao, Jingqi, Smith, Richard, Burton, Richard, Dow, Shannon, Perkins, Everett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834946/ https://www.ncbi.nlm.nih.gov/pubmed/24300450 http://dx.doi.org/10.3390/pharmaceutics5020261 |
Ejemplares similares
-
Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development
por: Wickremsinhe, Enaksha R, et al.
Publicado: (2021) -
Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties
por: Hong, Sungwoo, et al.
Publicado: (2018) -
Recent Development of Prodrugs of Gemcitabine
por: Pandit, Bhoomika, et al.
Publicado: (2022) -
Land O’Lakes Workshop on Microsampling: Enabling Broader Adoption
por: Wickremsinhe, Enaksha R, et al.
Publicado: (2020) -
Absorption and Excretion of Antipyrine
Publicado: (1888)